Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

The findings were alarming. People who took at least one anticholinergic drug had a 47% higher risk of developing memory ...

On Monday, the FDA accepted Eisai Co., Ltd. (OTC:ESALY) and Biogen Inc’s (NASDAQ:BIIB) Biologics License Application (BLA) ...

This has demonstrated the potential of palbociclib in treating Alzheimer’s disease,” Chen said. The research shows the drug ...

Firms developing Alzheimer’s drugs have already seen big peaks and troughs. Biogen shares soared 44% on a single day in November 2020 after news that an experimental drug appeared to be ...

In one study, the company’s drug eased the agitation for Alzheimer’s patients. In a different study, there wasn’t a ...

However, a recent study from Sunnybrook Research Institute offers some hope. Researchers found that a type of diabetes ...

Nootropics are touted as “smart drugs” meant to improve cognitive performance. But there’s a lot we still don’t know about ...

The finding has implications for all of us, write Harvard physician-researchers Christopher Worsham and Anupam Jena.

Anavex Life Sciences is back with more data for a pill that it’s looking to get approved in a variety of neurodegenerative ...